8th PR & Communications Summit

The 8th Public Relations and Communications Summit continues its tradition of excellence, featuring the most relevant case studies and actionable strategies to tackle the serious issues of the industry. This year brings together the top pharmaceutical communications executives, agency leaders, regulators, and thought leaders to discuss real take-home solutions, and offers an unrivaled opportunity for learning and networking. This summit provides you with perspectives from the FDA, strategies on adapting communications with consumers, utilizing social media initiatives and globalizing your communications.

Featured Session: 9-Time Emmy Award Winning Journalist Dr. Max Gomez Shares Media Perspectives

Featured Speakers

Top Reasons To Attend This Conference

• ExL Pharma’s 8th Public Relations & Communications is the most esteemed and established pharmaceutical and life science communications event with a proven track record of seven years of highly successful conferences.
• This year's summit features perspectives directly from the FDA on regulations and guidelines for digital initiatives and drug safety communications.
• This summit has case studies on efficient ways to combine internal and external communications; learn the best practices and strategies for learning to do more with less as many PR and communications budgets are being slashed.
• The event provides education and unparalleled networking to address hot topic issues such as: preparing for the changing regulatory environment, social media initiatives, crisis management, working with advocacy groups, and change management.
  
• New for 2012, the 8th Public Relations and Communications Summit features two 30 minutes intimate table review discussions - breakout with your peers at your table in the conference room for a review of the morning sessions. With your neighbors, share your own challenges, successes, ideas for improvement and gain takeaways that can be used when you return to your office.
  

Testimonials

"“Excellent content – Very applicable”
- Media relations, Covidien

“Very engaging, great content, well presented and always good to hear from the FDA”
- Director, Boehringer Ingelheim

Great topics and information… Surpassed my expectations!”
- Senior Director, Product Communications, Cephalon